Karyopharm Therapeutics Inc. (KPTI)
Data as of , from SEC Form 4 filings.
Net insider selling (90d)Watch KPTI
See up to 3 months of KPTI. The 7-day demo opens the 1M and 3M ranges and puts KPTI on your watchlist.
Start 7-day demoLatest KPTI insider trades
Kristin Abate - OfficerOpen-market sale$450- Kristin Abate - Officer
About Karyopharm Therapeutics Inc. (KPTI)
Karyopharm Therapeutics Inc. is an SEC registrant, filing under CIK 0001503802, classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
KPTI Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 3 | 586 | $2K |
KPTI insider transactions (Form 4)
3654 Form 4 filings on record, the earliest from Oct 7, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Kristin Abate - Officer | Open-market sale | Common Stock | 378 | $1.19 | $450 | |
| Kristin Abate - Officer | Open-market sale | Common Stock | 19 | $2.02 | $38 | |
 Stuart Poulton - Officer | Open-market sale | Common Stock | 189 | $7.10 | $1K | |
| Christy J. Oliger | Grant or award | Common Stock | 15,508 footnote F1 | $0.00 | - | |
| ||||||
| Deepika Pakianathan | Grant or award | Common Stock | 15,508 footnote F1 | $0.00 | - | |
| ||||||
| Chen Schor | Grant or award | Common Stock | 15,508 footnote F1 | $0.00 | - | |
| ||||||
 Zhen Su | Grant or award | Common Stock | 15,508 footnote F1 | $0.00 | - | |
| ||||||
| Garen G. Bohlin | Grant or award | Common Stock | 15,508 footnote F1 | $0.00 | - | |
| ||||||
| Barry E. Greene | Grant or award | Common Stock | 15,508 footnote F1 | $0.00 | - | |
| ||||||
| Stuart Poulton - Officer | Grant or award | Common Stock | 896 footnote F1 | $0.00 | - | |
| Stuart Poulton - Officer | Open-market sale | Common Stock | 403 | $9.50 | $4K | |
| ||||||
 Reshma Rangwala - Officer | Grant or award | Common Stock | 947 footnote F1 | $0.00 | - | |
| Reshma Rangwala - Officer | Open-market sale | Common Stock | 408 | $9.50 | $4K | |
| ||||||
 Sohanya Roshan Cheng - Officer | Grant or award | Common Stock | 947 footnote F1 | $0.00 | - | |
| Sohanya Roshan Cheng - Officer | Open-market sale | Common Stock | 324 | $9.50 | $3K | |
| ||||||
| Kristin Abate - Officer | Grant or award | Common Stock | 121 footnote F1 | $0.00 | - | |
| Kristin Abate - Officer | Open-market sale | Common Stock | 53 | $9.50 | $504 | |
| ||||||
 Richard A. Paulson - Officer | Grant or award | Common Stock | 4,920 footnote F1 | $0.00 | - | |
| Richard A. Paulson - Officer | Open-market sale | Common Stock | 2,203 | $9.50 | $21K | |
| ||||||
 Michael Mano - Officer | Grant or award | Common Stock | 700 footnote F1 | $0.00 | - | |
| Michael Mano - Officer | Open-market sale | Common Stock | 266 | $9.50 | $3K | |
| ||||||
| Reshma Rangwala - Officer | Open-market sale | Common Stock | 449 | $8.94 | $4K | |
| Kristin Abate - Officer | Open-market sale | Common Stock | 559 | $9.41 | $5K | |
| Michael Mano - Officer | Open-market sale | Common Stock | 3,526 | $9.41 | $33K | |
| Sohanya Roshan Cheng - Officer | Open-market sale | Common Stock | 4,604 | $9.41 | $43K | |
| Reshma Rangwala - Officer | Open-market sale | Common Stock | 5,066 | $9.41 | $48K | |
| Richard A. Paulson - Officer | Open-market sale | Common Stock | 12,361 | $9.41 | $116K | |
| Stuart Poulton - Officer | Open-market sale | Common Stock | 5,101 | $9.41 | $48K | |
| Stuart Poulton - Officer | Open-market sale | Common Stock | 378 | $8.63 | $3K | |
| Richard A. Paulson - Officer | Grant or award | Common Stock | 81,060 footnote F1 | $0.00 | - | |
| ||||||
| Lori Macomber - Officer | Open-market sale | Common Stock | 1,626 | $6.30 | $10K | |
| Sohanya Roshan Cheng - Officer | Grant or award | Common Stock | 32,415 footnote F1 | $0.00 | - | |
| ||||||
| Reshma Rangwala - Officer | Grant or award | Common Stock | 32,415 footnote F1 | $0.00 | - | |
| ||||||
| Lori Macomber - Officer | Grant or award | Common Stock | 32,415 footnote F1 | $0.00 | - | |
| ||||||
| Michael Mano - Officer | Grant or award | Common Stock | 32,415 footnote F1 | $0.00 | - | |
| ||||||
| Stuart Poulton - Officer | Grant or award | Common Stock | 32,415 footnote F1 | $0.00 | - | |
| ||||||
Item 8.01
Item 3.03, 5.03, 9.01
Item 1.01, 2.04, 3.02, 8.01, 9.01
Item 8.01
KPTI insider trading FAQ
What is the latest insider trade for KPTI?
Karyopharm Therapeutics Inc. (KPTI) had 3 insider filings in the last 90 days, with the most recent on 2026-10-02. The full record for KPTI runs to 54 Form 4 filings, the earliest from 2024-10-07. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying KPTI stock?
No insider purchases of KPTI were filed in the last 90 days.
How many insiders are selling KPTI stock?
3 insider sales of KPTI were filed in the last 90 days, totaling $2K.
Where can I see KPTI SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects KPTI Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Kristin Abate view on EDGAR
- - Kristin Abate view on EDGAR
- - Stuart Poulton view on EDGAR
- - Christy J. Oliger view on EDGAR
- - Deepika Pakianathan view on EDGAR
- - Chen Schor view on EDGAR
- - Zhen Su view on EDGAR
- - Garen G. Bohlin view on EDGAR
- - Barry E. Greene view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Insider activity in Health Care
- Where KPTI's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow KPTI with a 7-day demo
- KPTI on your watchlist
- Every KPTI Form 4 filing on record
- Up to 3 months of KPTI price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
